2Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4^+ cell count is 0. 2000 to 0.350 × 10^9 cells/L. Ann Intern Med, 2003,139:810-816. 被引量：1
3Reinke R, Steffen NR, Robinson WE Jr. Natural selection results in conservation of HIV-1 integrase activity despite sequence variability. AIDS,2001,15:823. 被引量：1
4Wai JS,Egbertson MS,Payne LS,et al.4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 Integrase and viral replication in cells. J Med Chem,2000,43:4923. 被引量：1
5Kwon HC, Jung CM, Shin CG, et al. A new caffeoy lquinic acid from aster scaber and its inhibitory activity against human immunodeficiency virus-1(HIV-1) integrase. Chem Pharm Bull (Tokyo),2000,48:1796. 被引量：1
6Kim SN, Lee JY, Kim HJ, et al. Synthesis and HIV-1 integrase inhibitory activities of caffeoyl glucosides. Bioorg Med Chem Lett,2000,10:1879. 被引量：1
7Rusnati M, Urbinati C, Caputo A, et al. Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem,2001,276:22420. 被引量：1
8Peters BS. HIV immunotherapeutic vaccines. Antivir Chem Chemother,2000,:311.11. 被引量：1
9O' Hagan D, Singh M, Ugozzoli M, et al. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J Virol, 2001,75: 9037. 被引量：1
10Re MC, Gibellini D, Vitone F, et al. Antibody to HIV-1 Tat protein, a key molecule in HIV-1 pathogenesis. New Microbial,2001,24:197. 被引量：1
